1999;10(15);2515–26. 67. Raper SE, Yudkoff M, Chirmule N, et al. A pilot study of in vivo liver -directed gene transfer with an adenoviral vector in partial ornithine transcarbam ylase deficiency . Hum Gene Ther. 2002;13(1):163-75. 68. Garon EB, Rizvi NA, Hui R, L eighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non -small - cell lung cancer. N Engl J Med. 2015; 372:2018–28. 69. Ji RR, Chasalow SD, Wang L, Hamid O, Schmidt H, Cogswell J, et al. Animmune- active tumor microenvironment fav ors clinical response to ipilimumab. Cancer Immunol Immunother. 2012;61:1019–31. 70. Tumeh PC, Harview CL, Yearley JH, Shintaku I P, Tay lor EJ, Robert L , et al. PD -1 blockade induces responses by inhibiting adaptive immune resistance. Nature.